SOUTH SAN FRANCISCO, Calif., October 21, 2021--(BUSINESS WIRE)--Graphite Bio, Inc. (Nasdaq: GRPH), a clinical-stage, next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases, announced today that members of the management team will participate in a fireside chat at the Jefferies Gene Therapy\/Editing Summit on Thursday, Oct. 28, 2021, at 4:30 p.m. ET.<\/p>\n
The fireside chat will be webcast live from Graphite Bios website at http:\/\/www.graphitebio.com<\/a> in the Investors section. A replay of the webcast will be archived and available for one month following the event.<\/p>\n About Graphite Bio<\/p>\n Graphite Bio is a clinical-stage, next-generation gene editing company harnessing high efficiency targeted gene integration to develop a new class of therapies to potentially cure a wide range of serious and life-threatening diseases. Graphite Bio is pioneering a precision gene editing approach that could enable a variety of applications to transform human health through its potential to achieve one of medicines most elusive goals: to precisely \"find & replace\" any gene in the genome. Graphite Bios platform allows it to precisely correct mutations, replace entire disease-causing genes with normal genes or insert new genes into predetermined, safe locations. The company was co-founded by academic pioneers in the fields of gene editing and gene therapy, including Maria Grazia Roncarolo, M.D., and Matthew Porteus, M.D., Ph.D.<\/p>\n Learn more about Graphite Bio by visiting http:\/\/www.graphitebio.com<\/a> and following the company on LinkedIn.<\/p>\n View source version on businesswire.com: https:\/\/www.businesswire.com\/news\/home\/20211021005108\/en\/<\/a><\/p>\n Contacts<\/p>\n Company: Stephanie YaoVP, Communications and Investor Relations443-739-1423syao@graphitebio.com<\/a><\/p>\n Investor Relations: Stephanie AscherStern IR, Inc.212-362-1200ir@graphitebio.com<\/a><\/p>\n Media: Christy CurranSam Brown, Inc.615-414-8668media@graphitebio.com<\/a><\/p>\n <\/p>\n Link: SOUTH SAN FRANCISCO, Calif., October 21, 2021--(BUSINESS WIRE)--Graphite Bio, Inc. Continue reading
\nGraphite Bio Announces Participation in Upcoming Jefferies Gene Therapy\/Editing Summit - Yahoo Finance<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"